160 related articles for article (PubMed ID: 25055831)
1. Concerns over data in key dabigatran trial.
Cohen D
BMJ; 2014 Jul; 349():g4747. PubMed ID: 25055831
[No Abstract] [Full Text] [Related]
2. Dabigatran-induced acute hepatitis.
Rochwerg B; Xenodemetropoulos T; Crowther M; Spyropoulos A
Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
[No Abstract] [Full Text] [Related]
3. Is there really misuse and abuse of dabigatran?
Eikelboom JW; Hankey GJ
Med J Aust; 2013 Apr; 198(7):358-9. PubMed ID: 23581946
[No Abstract] [Full Text] [Related]
4. Dabigatran monitoring made simple?
Eikelboom JW; Weitz JI
Thromb Haemost; 2013 Sep; 110(3):393-5. PubMed ID: 23884303
[No Abstract] [Full Text] [Related]
5. Dabigatran and postmarketing reports of bleeding.
Southworth MR; Reichman ME; Unger EF
N Engl J Med; 2013 Apr; 368(14):1272-4. PubMed ID: 23484796
[No Abstract] [Full Text] [Related]
6. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
Sipahi I; Celik S; Tozun N
JAMA Intern Med; 2014 Jan; 174(1):150-1. PubMed ID: 24247291
[No Abstract] [Full Text] [Related]
7. The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out.
Kowey PR; Naccarelli GV
Am J Med; 2012 Aug; 125(8):732. PubMed ID: 22608987
[No Abstract] [Full Text] [Related]
8. Dabigatran: life-threatening bleeding.
Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
[TBL] [Abstract][Full Text] [Related]
9. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
Kawabata M; Yokoyama Y; Sasano T; Hachiya H; Tanaka Y; Yagishita A; Sugiyama K; Nakamura T; Suzuki M; Isobe M; Hirao K
J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005
[TBL] [Abstract][Full Text] [Related]
10. The use, misuse and abuse of dabigatran.
Attia JR; Pearce R
Med J Aust; 2013 Apr; 198(7):356-7. PubMed ID: 23581945
[TBL] [Abstract][Full Text] [Related]
11. Place of dabigatran in contemporary pharmacotherapy.
Gums JG
Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622
[No Abstract] [Full Text] [Related]
12. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
Chen BC; Sheth NR; Dadzie KA; Smith SW; Nelson LS; Hoffman RS; Winchester JF
Am J Kidney Dis; 2013 Sep; 62(3):591-4. PubMed ID: 23597859
[TBL] [Abstract][Full Text] [Related]
13. [Anticoagulant therapy in connection with cardioversion in patients with atrial fibrillation].
Furman NV; Kuvshinova LE; Dovgalevskiĭ IaP
Kardiologiia; 2012; 52(9):69-76. PubMed ID: 23098549
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
Matute MC; Guillán M; García-Caldentey J; Buisan J; Aparicio M; Masjuan J; Alonso de Leciñana M
Thromb Haemost; 2011 Jul; 106(1):178-9. PubMed ID: 21505718
[No Abstract] [Full Text] [Related]
15. Dabigatran "non-inferior" to warfarin, but only just.
BMJ; 2013 Feb; 346():f1219. PubMed ID: 23447339
[No Abstract] [Full Text] [Related]
16. The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples.
Hapgood G; Butler J; Malan E; Chunilal S; Tran H
Thromb Haemost; 2013 Aug; 110(2):308-15. PubMed ID: 23783268
[TBL] [Abstract][Full Text] [Related]
17. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
Connolly SJ; Wallentin L; Ezekowitz MD; Eikelboom J; Oldgren J; Reilly PA; Brueckmann M; Pogue J; Alings M; Amerena JV; Avezum A; Baumgartner I; Budaj AJ; Chen JH; Dans AL; Darius H; Di Pasquale G; Ferreira J; Flaker GC; Flather MD; Franzosi MG; Golitsyn SP; Halon DA; Heidbuchel H; Hohnloser SH; Huber K; Jansky P; Kamensky G; Keltai M; Kim SS; Lau CP; Le Heuzey JY; Lewis BS; Liu L; Nanas J; Omar R; Pais P; Pedersen KE; Piegas LS; Raev D; Smith PJ; Talajic M; Tan RS; Tanomsup S; Toivonen L; Vinereanu D; Xavier D; Zhu J; Wang SQ; Duffy CO; Themeles E; Yusuf S
Circulation; 2013 Jul; 128(3):237-43. PubMed ID: 23770747
[TBL] [Abstract][Full Text] [Related]
18. Dabigatran-induced esophagitis.
Ootani A; Hayashi Y; Miyagi Y
Clin Gastroenterol Hepatol; 2014 Jul; 12(7):e55-6. PubMed ID: 24036049
[No Abstract] [Full Text] [Related]
19. Management of dabigatran-induced bleeding: expert statement.
Fries D; Giurea A; Gütl M; Halbmayer WM; Kozek-Langenecker S; Pachucki A; Roithinger F; Steinlechner B; Thaler H; Weltermann A
Wien Klin Wochenschr; 2013 Nov; 125(21-22):721-9. PubMed ID: 24217941
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran: a primer for neurosurgeons.
Fugate JE; Rabinstein AA; McBane RD; Lanzino G
World Neurosurg; 2013 Jan; 79(1):154-8. PubMed ID: 22722043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
